Literature DB >> 27786161

Characterization of fibropapillomatosis in green turtles Chelonia mydas (Cheloniidae) captured in a foraging area in southeastern Brazil.

Alícia Bertoloto Tagliolatto1, Suzana Machado Guimarães, Gisele Lobo-Hajdu, Cassiano Monteiro-Neto.   

Abstract

Fibropapillomatosis (FP) is a multifactorial disease that affects all species of marine turtles, including green turtles Chelonia mydas (Linnaeus, 1758). It is characterised by the development of internal or external tumours that, depending on their locations and sizes, may intensely impact the health condition of sea turtles. The goal of this study was to characterise the disease in C. mydas found in a foraging area in southeastern Brazil, evaluate the prevalence in this region, and correlate presence and absence, size, body distribution, number of tumours, and disease severity with biometric variables of the captured green turtles. Between 2008 and 2014, the prevalence rate of FP was 43.09%, out of 246 green turtles. The size of the animals with FP was relatively greater than animals without tumours, and the prevalence of FP increased with animal size, peaking in the 60-80 cm size class. From 2013 to 2014, gross evaluation of fibropapillomas was performed. The number of tumours per turtle ranged from 1 to 158. The size of tumours ranged from <1 cm (Size A) to >10 cm (Size D); Size A tumours and turtles slightly affected by the disease (Score 1) predominated. Tumour progression (72.1%) and regression (32.8%) were seen in some recaptured individuals (n = 61). Moreover, 24.6% of these turtles showed both progressions and regressions of tumours.

Entities:  

Keywords:  Disease; Fibropapilloma; Prevalence; Progression; Regression; Tumour

Mesh:

Year:  2016        PMID: 27786161     DOI: 10.3354/dao03020

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  1 in total

1.  Health assessment of juvenile green turtles in southern São Paulo State, Brazil: a hematologic approach.

Authors:  Daniela M D de Mello; Maria C L Alvarez
Journal:  J Vet Diagn Invest       Date:  2019-12-17       Impact factor: 1.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.